NIRALI PATEL: Open Payments
NPI 1356110670 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $161 |
| GlaxoSmithKline, LLC. | 2 | $131 |
| SANOFI-AVENTIS U.S. LLC | 4 | $87 |
| Astellas Pharma US Inc | 2 | $60 |
| PFIZER INC. | 2 | $38 |
| ABBVIE INC. | 1 | $29 |
| Exact Sciences Corporation | 2 | $28 |
| MERZ NORTH AMERICA, INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
Products named: AREXVY, MOUNJARO, TZIELD, Veozah, JARDIANCE, PREVNAR 20, QULIPTA, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
